HEIDELBERG, Germany, Nov 17 (Bernama-PRNewswire) — European Wellness Academy (EWA), a member of European Wellness Biomedical Group (EWBG), recently signed its second research contract involving General In Vitro/In Vivo Safety and Toxicity Tests for Preclinical Studies of Regenerative Peptides with Heidelberg University.
The research contract signed is a continuation of the previous research on the efficacy of the Group’s cutting-edge biotherapeutics including precursor (progenitor) stem cells (PSC), precursor cells (Frozen Organo Crygenics (FOC)), Mito Organelles (MO), Nano Organo Peptides (NOP) and exosomes.
- 34 Killed, 80 Injured In Barbaric Israeli Airstrikes On Lebanon
- Zionist Israeli Airstrikes Hit Syria-Lebanon Border Crossing: Media
- COP29: Rich nations raise cash offer to $300 billion to poor nations in climate talks
- Iraq Warns Of Possible Israeli Attacks In Letters To UN
- UN: 343 million people across 74 countries ‘acutely food insecure’
- 18 Killed, Over 30 Injured In Armed Clashes In NW Pakistan
- India’s Main Ruling Party BJP-Led Alliance Wins Key State Maharashtra
- Authorities To Deploy Over 10,000 Additional Paramilitary Troopers In India’s Manipur
- Top DPRK Leader Calls For Upgrading Military Equipment
- 420,000 Syrian Refugees Return From Lebanon Due To Hezbollah-Israel Conflict